Literature DB >> 9371589

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

R M Powell1, T Ward, D J Evans, J W Almond.   

Abstract

Soluble forms of decay-accelerating factor (DAF) (CD55), the receptor for echovirus 7, were synthesized in the yeast Pichia pastoris. Purified recombinant protein containing SCR domains 2, 3, and 4, but lacking the serine/threonine rich region, was shown to block infection of susceptible cells by echovirus 7. In contrast to the situation with poliovirus and its receptor, the neutralization of echovirus 7 by soluble DAF was completely reversible and did not lead to the formation of 135S A-particles. Binding of virus to susceptible cells, by contrast, did lead to the formation of A particles, mainly from virus that had been internalized. The data suggest that a secondary factor(s) may contribute to A-particle formation and uncoating of echovirus 7.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371589      PMCID: PMC230233     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  PURIFICATION AND CHEMICAL ANALYSIS OF THE ERYTHROCYTE RECEPTOR FOR HEMAGGLUTINATING ENTEROVIRUSES.

Authors:  L PHILIPSON; S BENGTSSON; S BRISHAMMAR; L SVENNERHOLM; O ZETTERQVIST
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

2.  Identification of the integrin VLA-2 as a receptor for echovirus 1.

Authors:  J M Bergelson; M P Shepley; B M Chan; M E Hemler; R W Finberg
Journal:  Science       Date:  1992-03-27       Impact factor: 47.728

3.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Neutralization of poliovirus by cell receptors expressed in insect cells.

Authors:  G Kaplan; M S Freistadt; V R Racaniello
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.

Authors:  K E Coyne; S E Hall; S Thompson; M A Arce; T Kinoshita; T Fujita; D J Anstee; W Rosse; D M Lublin
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

6.  Characterization of poliovirus conformational alteration mediated by soluble cell receptors.

Authors:  A Gómez Yafal; G Kaplan; V R Racaniello; J M Hogle
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

Review 7.  Recent advances in the expression of foreign genes in Pichia pastoris.

Authors:  J M Cregg; T S Vedvick; W C Raschke
Journal:  Biotechnology (N Y)       Date:  1993-08

8.  Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

Authors:  D Naniche; G Varior-Krishnan; F Cervoni; T F Wild; B Rossi; C Rabourdin-Combe; D Gerlier
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Uncoating of poliovirus by isolated plasma membranes.

Authors:  V F Chan; F L Black
Journal:  J Virol       Date:  1970-03       Impact factor: 5.103

10.  Specific alterations of coxsackievirus B3 eluted from HeLa cells.

Authors:  R L Crowell; L Philipson
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

View more
  34 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 2.  Complement deficiency.

Authors:  K M O'Neil
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  The major structural subunits of Dr and F1845 fimbriae are adhesins.

Authors:  Cristina P Van Loy; Evgeni V Sokurenko; Steve L Moseley
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

Authors:  Yongning He; Feng Lin; Paul R Chipman; Carol M Bator; Timothy S Baker; Menachem Shoham; Richard J Kuhn; M Edward Medof; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

5.  Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Authors:  Amanda D Stuart; Thomas A McKee; Pamela A Williams; Chris Harley; Shuo Shen; David I Stuart; T David K Brown; Susan M Lea
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Fatty acid-depleted albumin induces the formation of echovirus A particles.

Authors:  T Ward; R M Powell; Y Chaudhry; J Meredith; J W Almond; W Kraus; B Nelsen-Salz; H J Eggers; D J Evans
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Authors:  Jennifer White; Petra Lukacik; Dirk Esser; Michael Steward; Naomi Giddings; Jeremy R Bright; Sarah J Fritchley; B Paul Morgan; Susan M Lea; Geoffrey P Smith; Richard A G Smith
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

9.  Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells.

Authors:  T Ward; R M Powell; P A Pipkin; D J Evans; P D Minor; J W Almond
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection.

Authors:  X Wang; J M Bergelson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.